A Phase I Open Label, Randomised, Single Dose, 2-Way Crossover, 2-Sequence Pharmacokinetic Study on the Interaction of Colesevelam and Ciclosporin in Healthy Volunteers

Trial Profile

A Phase I Open Label, Randomised, Single Dose, 2-Way Crossover, 2-Sequence Pharmacokinetic Study on the Interaction of Colesevelam and Ciclosporin in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 08 May 2015

At a glance

  • Drugs Ciclosporin (Primary) ; Colesevelam (Primary)
  • Indications Heart transplant rejection; Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemia type IIa; Liver transplant rejection; Pancreas transplant rejection; Psoriasis; Renal transplant rejection; Rheumatoid arthritis; Transplant rejection; Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Genzyme Corporation
  • Most Recent Events

    • 05 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top